Relisys Medical Devices

Executive Summary

Relisys Medical Devices Ltd. is an Indian med-tech company established in 2003 that designs, manufactures, and markets cardiovascular devices, including coronary stents (bare-metal and drug-eluting), PTCA balloons, diagnostic and guiding catheters, and transcatheter heart valves. Leveraging an integrated R&D-to-manufacturing platform, the company focuses on delivering affordable, high-quality solutions for coronary artery disease, peripheral artery disease, and valvular heart disease. Operating primarily in India, Relisys benefits from the country's rapidly expanding medical device market, driven by rising cardiovascular disease prevalence and increasing healthcare access. The company's commitment to cost-effective innovation positions it well to capture market share in both domestic and emerging international markets. While Relisys is a private company with limited public financial disclosure, its long operational history and comprehensive product portfolio suggest a stable business model. The company's ability to navigate regulatory pathways and maintain quality standards will be key to its growth trajectory.

Upcoming Catalysts (preview)

• Q3 2026FDA approval for a next-generation drug-eluting stent60% success
• Q2 2026Launch of a novel transcatheter heart valve in India50% success
• Q4 2026Strategic partnership with a global distributor for peripheral devices70% success